P/B
—
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
$793.2M
Market Cap • 10/9/2026
2015
(11 years)
Founded
2025
(1 year ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
6,7
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
793,2M
EV
748,9M
EV/Revenue
6,3
EV/EBITDA
-9,3
EV/EBIT
-9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,8%
Total Yield
-0,8%
Payout
0%
Profitability
Gross Margin
58,3%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
32,7%
Capex/Revenue
4,7%
Capex/D&A
252,6%
Capex/OCF
-10%
SBC/OCF
—
% PPE
0%
% Goodwill
0%
ROE
—
ROIC
—
Leverage
N.D./EBITDA
0,5
Debt/Equity
0%
Current Ratio
0
Quick Ratio
0
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!